Abstract

Low-dose Pilocarpine Spray to Treat Xerostomia

Author(s): Zur Eyal

Issue: Mar/Apr 2020 - Volume 24, Number 2

Page(s): 104-108

Download in electronic PDF format for $75

Abstract

Although pilocarpine hydrochloride tablets are currently indicated for the treatment of xerostomia, their adverse effects are frequently reported. The development of a new, low-dose pilocarpine solution for topical oral-cavity use is needed. This article discusses a few clinical trials to formulate a topical low-dose solution of pilocarpine hydrochloride for the treatment of xerostomia and presents two low dose, stable formulations of pilocarpine topical spray that can improve the patient's quality of life with minimal adverse effects.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2020 Pg. 104-108	Low-dose Pilocarpine Spray to Treat Xerostomia Author(s): Zur Eyal
Mar/Apr 2023 Pg. 149-151	Pilocarpine Hydrochloride 0.3% w/v Solution Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 197-201	Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Author(s): Sturn Kayla M, Collin Michael
Nov/Dec 2023 Pg. 468-473	Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management Author(s): Rodriguez Franklin, Carvalho Maria, Banov Fabiana
Mar/Apr 2010 Pg. 171-173	Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Jul/Aug 2018 Pg. 270-278	Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
Mar/Apr 2020 Pg. 94-96	Low-dose Naltrexone Therapy for Psoriasis Author(s): Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Mar/Apr 2012 Pg. 117-124	Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Author(s): Zur Eyal
May/Jun 2000 Pg. 215	Saliva Substitute for Dry Mouth/Throat Author(s): Allen Loyd V Jr
Sep/Oct 2000 Pg. 338	Clinical Management and Review of Sjogren's Syndrome Author(s): Dyke Shannon
May/Jun 2000 Pg. 176-177	Xerostomia Author(s): Kuntz Rachael, Allen Michelle, Osburn Jennifer
Jul/Aug 2000 Pg. 255	Dry Mouth Spray Author(s): Horwitz Robert
May/Jun 2012 Pg. 196-205	Burning Mouth Syndrome: A Discussion of a Complex Pathology Author(s): Zur Eyal
Jul/Aug 2000 Pg. 257-260	Surviving Cancer - How the Compounding Pharmacist Can Help Author(s): Maddox Suzan
Nov/Dec 2003 Pg. 460-463 View Sample	Basics of Compounding for Dry-Skin Conditions Author(s): Allen Loyd V Jr
Sep/Oct 2000 Pg. 381	Pilocarpine HCl 2-mg Troches Author(s): Allen Loyd V Jr
May/Jun 2000 Pg. 177	Pilocarpine Oral Solution Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Mar/Apr 2016 Pg. 147	Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Author(s): Allen Loyd V Jr
Jan/Feb 2003 Pg. 27-29	Equine Cushing’s Syndrome Author(s): Vail Jane